Astellas Reports First Quarter Financial Results of FY2016 - Business Wire (press release)
Astellas Reports First Quarter Financial Results of FY2016Business Wire (press release)This reflected underlying growth in sales of products including overall OAB treatments (Vesicare® and Betanis®), Celecox® (celecoxib) and Symbicort® (budesonide and formoterol fumarate dihydrate).
AstraZeneca (AZN) Tops Q2 EPS by 7c - StreetInsider.com
AstraZeneca (AZN) Tops Q2 EPS by 7cStreetInsider.
Glaxo stokes triple-combo hopes with data topping AZ's Symbicort - FiercePharma
FiercePharmaGlaxo stokes triple-combo hopes with data topping AZ's SymbicortFiercePharmaMonday, the company announced that the pipeline med had nailed both of its primary endpoints in a Phase III study, topping rival Symbicort from AstraZeneca on metrics measuring lung function and health-related quality of life.
Which Growth Platforms Will Drive AstraZeneca's 2Q16 Earnings? - Market Realist
Market RealistWhich Growth Platforms Will Drive AstraZeneca's 2Q16 Earnings?Market RealistThe respiratory product sales are expected to increase operationally due to revenues from the blockbuster drugs Symbicort and Pulmicort, as well as new products including Tudorza, Daliresp, and Duaklir.
Finland calls on WADA to check Norwegian skiers with asthma for doping - RT
RTFinland calls on WADA to check Norwegian skiers with asthma for dopingRTIn 2011, WADA legalized the anti-asthma drug symbicort, which was being used by famous Norwegian skier Marit Bjoergen at that time.